These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 17407390)
1. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy. Yokoyama K; Yang W; Preblick R; Frech-Tamas F J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390 [TBL] [Abstract][Full Text] [Related]
2. Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers. Zhang D; Carlson AM; Gleason PP; Schondelmeyer SW; Schommer JC; Dowd BE; Heaton AH J Manag Care Pharm; 2007 Oct; 13(8):664-76. PubMed ID: 17970604 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of sword swallowing and pharmaceutical step-therapy interventions. Curtiss FR J Manag Care Pharm; 2007 Apr; 13(3):284-6. PubMed ID: 17407396 [No Abstract] [Full Text] [Related]
4. Assessing step-therapy programs:a step in the right direction. Gleason PP J Manag Care Pharm; 2007 Apr; 13(3):273-5. PubMed ID: 17407393 [No Abstract] [Full Text] [Related]
5. Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care. Hurwitz JT; Grizzle AJ; Augustine J; Rehfeld R; Wild A; Abraham I J Manag Care Spec Pharm; 2016 Jan; 22(1):40-8. PubMed ID: 27015050 [TBL] [Abstract][Full Text] [Related]
6. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. Lee HY; Cooke CE; Robertson TA J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049 [TBL] [Abstract][Full Text] [Related]
7. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan. Johnson JT; Neill KK; Davis DA J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy. Wen X; Otoo MN; Tang J; Brothers T; Ward KE; Asal N; Meador KJ JAMA Neurol; 2024 Aug; 81(8):866-874. PubMed ID: 38884986 [TBL] [Abstract][Full Text] [Related]
9. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis. Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917 [TBL] [Abstract][Full Text] [Related]
10. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication? Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212 [TBL] [Abstract][Full Text] [Related]
11. Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs. Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB J Am Pharm Assoc (2003); 2010; 50(4):527-31. PubMed ID: 20621872 [TBL] [Abstract][Full Text] [Related]
12. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan. Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053 [TBL] [Abstract][Full Text] [Related]
13. Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment. Wettermark B; Godman B; Neovius M; Hedberg N; Mellgren TO; Kahan T Health Policy; 2010 Mar; 94(3):221-9. PubMed ID: 19879009 [TBL] [Abstract][Full Text] [Related]
14. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization. Cooke CE; Fatodu H J Manag Care Pharm; 2006 Oct; 12(8):649-55. PubMed ID: 17269843 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive medication changes and blood pressure goal achievement in a managed care population. Engel-Nitz NM; Darkow T; Lau H J Hum Hypertens; 2010 Oct; 24(10):659-68. PubMed ID: 20107489 [TBL] [Abstract][Full Text] [Related]
16. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy. Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240 [TBL] [Abstract][Full Text] [Related]
18. Association of Long-term Use of Antihypertensive Medications With Late Outcomes Among Patients With Aortic Dissection. Chen SW; Chan YH; Lin CP; Wu VC; Cheng YT; Chen DY; Chang SH; Hung KC; Chu PH; Chou AH JAMA Netw Open; 2021 Mar; 4(3):e210469. PubMed ID: 33656527 [TBL] [Abstract][Full Text] [Related]
19. [Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance]. Laux G; Szecsenyi J; Miksch A; Grün B; Gutscher A; Grün B; Rosemann T; Kühlein T Med Klin (Munich); 2009 Feb; 104(2):108-13. PubMed ID: 19242661 [TBL] [Abstract][Full Text] [Related]
20. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions. Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]